Suppliers and packages for NDA: 204071
✉ Email this page to a colleague
204071
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
---|---|---|---|---|---|---|---|---|---|
Nuvo Pharms Inc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 204071 | ANDA | Marlex Pharmaceuticals Inc | 10135-146-14 | 15 g in 1 BOTTLE, PLASTIC (10135-146-14) | 2016-03-01 |
Nuvo Pharms Inc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 204071 | ANDA | Marlex Pharmaceuticals Inc | 10135-146-17 | 454 g in 1 JAR (10135-146-17) | 2016-03-01 |
Nuvo Pharms Inc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 204071 | ANDA | SUNRISE PHARMACEUTICAL, INC. | 11534-166-15 | 15 g in 1 BOTTLE (11534-166-15) | 2017-01-24 |
Nuvo Pharms Inc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 204071 | ANDA | SUNRISE PHARMACEUTICAL, INC. | 11534-166-16 | 15 g in 1 BOTTLE (11534-166-16) | 2017-01-24 |
Nuvo Pharms Inc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 204071 | ANDA | SUNRISE PHARMACEUTICAL, INC. | 11534-166-44 | 454 g in 1 JAR (11534-166-44) | 2017-01-24 |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |